CD79A and metabolic syndrome: Previous research in pre-clinical models showed how a deficiency in the innate adaptor molecule Myd88 leads to impaired development of T follicular helper cells and reduced IgA production in the gut, subsequently impacting the microbiota and leading to a metabolic syndrome [63].